{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:13:31Z","timestamp":1787022811381,"version":"build-2736575974"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Concurrent autonomous cortisol secretion (ACS) in patients with primary aldosteronism (PA) is being reported more frequently. Several somatic mutations including PRKACA, GNAS, and CTNNB1 were identified in cortisol-producing adenomas (CPAs). The presence of these mutations in unilateral PA (uPA) patients concurrent with ACS (uPA\/ACS) is not well known. This study aimed to investigate the prevalence of these mutations and their clinical vs pathological characteristics in uPA\/ACS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>This is a retrospective cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Totally 98 uPA patients from the Taiwan Primary Aldosteronism Investigation registry having overnight 1-mg dexamethasone suppression test (DST) and adrenalectomy from 2016 to 2018 were enrolled. Their adrenal tumors were tested for PRKACA, GNAS, and CTNNB1 mutations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>11 patients had CPA-related mutations (7 PRKACA and 4 GNAS). The patients carrying these mutations had higher post-DST cortisol (5.6 vs 2.6 \u03bcg\/dL, P = 0.003) and larger adenoma (2.2 \u00b1 0.3 vs 1.9 \u00b1 0.7 cm, P = 0.025). Adenomas with these mutations had a higher prevalence of non-classical uPA (72.7% vs 26.3%, P = 0.014). Numerically, slightly more complete clinical success of uPA patients with these mutations was noticed after adrenalectomy, although it was statistically non-significant. Post-DST cortisol levels, adenoma size &amp;gt;1.9 cm, and the interaction of adenoma size &amp;gt;1.9 cm with potassium level were found to be associated with the presence of these mutations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study showed that CPA-related mutations were detected in 36.7% of uPA\/ACS adenomas. The presence of these mutations was associated with higher post-DST cortisol levels, larger adenoma sizes, and a high percentage of non-classical uPA. However, these mutations did not significantly affect the clinical and biochemical outcomes after adrenalectomy of uPA\/ACS patients but they showed a better trend.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/eje-22-0286","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T09:08:47Z","timestamp":1658221727000},"page":"519-530","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-7","source":"Crossref","is-referenced-by-count":12,"title":["Cortisol-producing adenoma-related somatic mutations in unilateral primary aldosteronism with concurrent autonomous cortisol secretion: their prevalence and clinical characteristics"],"prefix":"10.1093","volume":"187","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2731-5331","authenticated-orcid":false,"given":"Wan-Chen","family":"Wu","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital , Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang-Yung","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital , Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ying","family":"Lu","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital , Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh-Kai","family":"Chan","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch , Hsinchu City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital , Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen-Yu","family":"Tseng","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital , Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Shiung","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital , Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8153-1441","authenticated-orcid":false,"given":"Yen-Hung","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital , Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Chih","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital , Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Chu","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch , Hsinchu City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-How","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Urology, National Taiwan University Hospital , Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff S","family":"Chueh","sequence":"additional","affiliation":[{"name":"Department of Urology, National Taiwan University Hospital , Taipei, Taiwan"},{"name":"Department of Urology, College of Medicine, National Taiwan University , Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7935-0991","authenticated-orcid":false,"given":"Vin-Cent","family":"Wu","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital , Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,9,14]]},"reference":[{"key":"2023010809172006900_bib1","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2023010809172006900_bib2","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"Journal of the American College of Cardiology"},{"key":"2023010809172006900_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0889-8529(05)70115-8","article-title":"Subclinical Cushing's syndrome","volume":"29","author":"Reincke","year":"2000","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"key":"2023010809172006900_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-2265.1998.00357.x","article-title":"Subclinical Cushing's syndrome in adrenal incidentaloma","volume":"48","author":"Terzolo","year":"1998","journal-title":"Clinical Endocrinology"},{"key":"2023010809172006900_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.beem.2009.04.001","article-title":"Management of adrenal incidentaloma","volume":"23","author":"Terzolo","year":"2009","journal-title":"Best Practice and Research: Clinical Endocrinology and Metabolism"},{"key":"2023010809172006900_bib6","first-page":"564","article-title":"Primary aldosteronism associated with subclinical Cushing syndrome","volume":"36","author":"Fujimoto","year":"2013","journal-title":"Journal of Endocrinological Investigation"},{"key":"2023010809172006900_bib7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1530\/EJE-10-1070","article-title":"Aldosterone- and cortisol-co-secreting adrenal tumors: the lost subtype of primary aldosteronism","volume":"164","author":"Spath","year":"2011","journal-title":"European Journal of Endocrinology"},{"key":"2023010809172006900_bib8","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1097\/HJH.0b013e32834937f3","article-title":"Concurrent primary aldosteronism and subclinical cortisol hypersecretion: a prospective study","volume":"29","author":"Fallo","year":"2011","journal-title":"Journal of Hypertension"},{"key":"2023010809172006900_bib9","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1210\/jc.2010-2743","article-title":"Cardiovascular complications of patients with aldosteronism associated with autonomous cortisol secretion","volume":"96","author":"Nakajima","year":"2011","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2023010809172006900_bib10","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/HYPERTENSIONAHA.120.15328","article-title":"Presence of subclinical hypercortisolism in clinical aldosterone-producing adenomas predicts lower clinical success","volume":"76","author":"Peng","year":"2020","journal-title":"Hypertension"},{"key":"2023010809172006900_bib11","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2337\/dc18-1293","article-title":"High prevalence of diabetes in patients with primary aldosteronism (PA) associated with subclinical hypercortisolism and prediabetes more prevalent in bilateral than unilateral PA: a large, multicenter cohort study in Japan","volume":"42","author":"Akehi","year":"2019","journal-title":"Diabetes Care"},{"key":"2023010809172006900_bib12","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1210\/jc.2018-00617","article-title":"Cortisol excess in patients with primary aldosteronism impacts left ventricular hypertrophy","volume":"103","author":"Adolf","year":"2018","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2023010809172006900_bib13","doi-asserted-by":"crossref","first-page":"E2093","DOI":"10.1210\/jc.2014-2152","article-title":"Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric study","volume":"99","author":"Di Dalmazi","year":"2014","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2023010809172006900_bib14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1530\/EJE-14-1113","article-title":"PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases","volume":"172","author":"Thiel","year":"2015","journal-title":"European Journal of Endocrinology"},{"key":"2023010809172006900_bib15","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing's syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"key":"2023010809172006900_bib16","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/cen.13134","article-title":"Clinical characteristics of PRKACA mutations in Chinese patients with adrenal lesions: a single-centre study","volume":"85","author":"Li","year":"2016","journal-title":"Clinical Endocrinology"},{"key":"2023010809172006900_bib17","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1210\/jc.2016-1700","article-title":"PRKACA somatic mutations are rare findings in aldosterone-producing adenomas","volume":"101","author":"Rhayem","year":"2016","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2023010809172006900_bib18","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/HYPERTENSIONAHA.118.12070","article-title":"Genetic characteristics of aldosterone-producing adenomas in blacks","volume":"73","author":"Nanba","year":"2019","journal-title":"Hypertension"},{"key":"2023010809172006900_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1507\/endocrj.EJ15-0642","article-title":"GNAS mutations in adrenal aldosterone-producing adenomas. (Rapid Communication)","volume":"63","author":"Nakajima","year":"2016","journal-title":"Endocrine Journal"},{"key":"2023010809172006900_bib20","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s12020-017-1295-4","article-title":"Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series","volume":"58","author":"Fallo","year":"2017","journal-title":"Endocrine"},{"key":"2023010809172006900_bib21","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/hmg\/ddt484","article-title":"WNT\/beta-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production","volume":"23","author":"Berthon","year":"2014","journal-title":"Human Molecular Genetics"},{"key":"2023010809172006900_bib22","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/ng.2956","article-title":"Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors","volume":"46","author":"Goh","year":"2014","journal-title":"Nature Genetics"},{"key":"2023010809172006900_bib23","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jfma.2017.06.004","article-title":"Case detection and diagnosis of primary aldosteronism \u2013 the consensus of Taiwan Society of Aldosteronism","volume":"116","author":"Wu","year":"2017","journal-title":"Journal of the Formosan Medical Association"},{"key":"2023010809172006900_bib24","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jclinepi.2014.05.012","article-title":"Administrative data on diagnosis and mineralocorticoid receptor antagonist prescription identified patients with primary aldosteronism in Taiwan","volume":"67","author":"Wu","year":"2014","journal-title":"Journal of Clinical Epidemiology"},{"key":"2023010809172006900_bib25","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/ajh.2009.89","article-title":"Primary aldosteronism: diagnostic accuracy of the losartan and captopril tests","volume":"22","author":"Wu","year":"2009","journal-title":"American Journal of Hypertension"},{"key":"2023010809172006900_bib26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/1470320310391329","article-title":"Verification and evaluation of aldosteronism demographics in the Taiwan Primary Aldosteronism Investigation Group (TAIPAI Group)","volume":"12","author":"Kuo","year":"2011","journal-title":"Journal of the Renin-Angiotensin-Aldosterone System"},{"key":"2023010809172006900_bib27","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1097\/HJH.0b013e3283495cbb","article-title":"Primary aldosteronism: changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment","volume":"29","author":"Wu","year":"2011","journal-title":"Journal of Hypertension"},{"key":"2023010809172006900_bib28","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.cca.2011.02.018","article-title":"Kidney impairment in primary aldosteronism","volume":"412","author":"Wu","year":"2011","journal-title":"Clinica Chimica Acta: International Journal of Clinical Chemistry"},{"key":"2023010809172006900_bib29","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/ajh\/hpz098","article-title":"Plasma aldosterone after seated saline infusion test outperforms captopril test at predicting clinical outcomes after adrenalectomy for primary aldosteronism","volume":"32","author":"Wu","year":"2019","journal-title":"American Journal of Hypertension"},{"key":"2023010809172006900_bib30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1210\/clinem\/dgaa484","article-title":"International histopathology consensus for unilateral primary aldosteronism","volume":"106","author":"Williams","year":"2021","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2023010809172006900_bib31","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the study of adrenal tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"European Journal of Endocrinology"},{"key":"2023010809172006900_bib32","first-page":"689","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet: Diabetes and Endocrinology"},{"key":"2023010809172006900_bib33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mce.2013.11.022","article-title":"Development of monoclonal antibodies against human CYP11B1 and CYP11B2","volume":"383","author":"Gomez-Sanchez","year":"2014","journal-title":"Molecular and Cellular Endocrinology"},{"key":"2023010809172006900_bib34","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1161\/HYPERTENSIONAHA.121.17348","article-title":"Single-center prospective cohort study on the histopathology, genotype, and postsurgical outcomes of patients With primary aldosteronism","volume":"78","author":"Meyer","year":"2021","journal-title":"Hypertension"},{"key":"2023010809172006900_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12902-020-0490-0","article-title":"Clinical characterization of patients with primary aldosteronism plus subclinical Cushing's syndrome","volume":"20","author":"Yasuda","year":"2020","journal-title":"BMC Endocrine Disorders"},{"key":"2023010809172006900_bib36","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1507\/endocrj.K10E-402","article-title":"Clinicopathological features of primary aldosteronism associated with subclinical Cushing's syndrome","volume":"58","author":"Hiraishi","year":"2011","journal-title":"Endocrine Journal"},{"key":"2023010809172006900_bib37","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2265.2000.01022.x","article-title":"Concurrent secretion of aldosterone and cortisol from an adrenal adenoma \u2013 value of MRI in diagnosis","volume":"53","author":"Allan","year":"2000","journal-title":"Clinical Endocrinology"},{"key":"2023010809172006900_bib38","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1310359","article-title":"Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome","volume":"370","author":"Beuschlein","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"2023010809172006900_bib39","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fmed.2018.00054","article-title":"The many faces of primary aldosteronism and Cushing syndrome: a reflection of adrenocortical tumor heterogeneity","volume":"5","author":"Mete","year":"2018","journal-title":"Frontiers in Medicine"},{"key":"2023010809172006900_bib40","doi-asserted-by":"crossref","first-page":"4920841","DOI":"10.1155\/2018\/4920841","article-title":"Clinical characteristics of aldosterone- and cortisol-coproducing adrenal adenoma in primary aldosteronism","volume":"2018","author":"Tang","year":"2018","journal-title":"International Journal of Endocrinology"},{"key":"2023010809172006900_bib41","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fendo.2016.00075","article-title":"Intracellular molecular differences in aldosterone-compared to cortisol-secreting adrenal cortical adenomas","volume":"7","author":"Seidel","year":"2016","journal-title":"Frontiers in Endocrinology"},{"key":"2023010809172006900_bib42","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1210\/jc.2016-1586","article-title":"Genetic landscape of sporadic unilateral adrenocortical adenomas without PRKACA p.Leu206Arg mutation","volume":"101","author":"Ronchi","year":"2016","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2023010809172006900_bib43","doi-asserted-by":"crossref","first-page":"E419","DOI":"10.1210\/jc.2010-1885","article-title":"Wnt\/beta-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors","volume":"96","author":"Bonnet","year":"2011","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2023010809172006900_bib44","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1507\/endocrj.EJ12-0247","article-title":"KCNJ5 mutations in aldosterone- and cortisol-co-secreting adrenal adenomas","volume":"59","author":"Yamada","year":"2012","journal-title":"Endocrine Journal"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/187\/4\/EJE-22-0286.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eje.bioscientifica.com\/downloadpdf\/journals\/eje\/187\/4\/EJE-22-0286.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/187\/4\/519\/48515844\/eje-22-0286.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/187\/4\/519\/48515844\/eje-22-0286.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T11:18:05Z","timestamp":1676373485000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/187\/4\/519\/6972081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,14]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10,1]]}},"URL":"https:\/\/doi.org\/10.1530\/eje-22-0286","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10]]},"published":{"date-parts":[[2022,9,14]]}}}